Florida Cancer Specialists Renjitha Ignatius, MD Nominated for Leukemia & Lymphoma Society’s Woman of the Year
Sun City, FL – May 6, 2019… Florida Cancer Specialists & Research Institute (FCS) is pleased to announce that Dr. Renjitha Ignatius has been nominated by the Sun Coast Chapter of the Leukemia & Lymphoma Society (LLS) as Woman of the Year for 2019. After an intensive nominating and vetting process, Dr. Ignatius accepted the challenge to engage in a spirited competition to raise funds for blood cancer research and patient support programs, which could earn her the coveted title of “Woman of the Year.”
Dr. Renjitha Ignatius, who practices at the FCS Sun City Center office, said, “I am personally honored to be nominated, along with my colleagues at FCS, to help raise funds for vital research and patient programs.
LLS lessens the burden for our patients and families through education and financial assistance; through their partnership with oncologists like me, LLS works hard to make a difference in the lives of those living with hematologic malignancies.”
During medical school, Dr. Ignatius had the distinct honor of graduating among the top five students in her class. She completed both her Internal Medicine Residency and Fellowship in Medical Oncology at Oakland University William Beaumont School of Medicine in Royal Oak, MI. Before moving to Florida, Dr. Ignatius served as Associate Professor for Oakland University William Beaumont School of Medicine and was in private practice for six years in Royal Oak, MI.
Dr. Ignatius has been an active participant in numerous multidisciplinary tumor clinics and has been published in several peer-reviewed journals, including the prestigious Journal of Clinical Oncology. Her areas of interest include malignancies of the breast, head, and neck, as well as gastrointestinal and genitourinary cancers. Dr. Ignatius has extensive experience in treating patients with central nervous system cancers, lung cancer, and hematological conditions. She believes in personalized care for patients, utilizing the best evidence-based treatments available.
FCS CEO, Bradley Prechtl, MBA, said, “So many of our physicians go far beyond their professional commitment of treating cancer patients by agreeing to support fundraising efforts such as this. It is a testimony to the level of compassion and care our doctors have for their patients.”
Dr. Lucio Gordan, FCS President & Managing Physician, added, “As an oncologist and hematologist, I am committed to advancing research that can provide critical knowledge about all forms of cancer. Organizations such as LLS help us do just that and it is particularly gratifying to see so many of the FCS physicians who are willing to contribute to such a deserving organization.
To vote for Dr. Ignatius, go to FLCancer.com/IgnatiusMWOY19. This link will take you to Dr. Ignatius’ personal web page, where you may donate to the Leukemia & Lymphoma Society. Every dollar donated counts as one vote for Dr. Ignatius.
About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. In the past 4 years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.* Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, M.D. Anderson, and Memorial Sloan Kettering, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.
Founded in 1984, FCS is one of the largest medical oncology/hematology practices in the United States. With more than 230 physicians, 220 advanced practice registered nurses (APRN) and physician assistants (PA) and nearly 100 locations in our network, we are committed to providing world-class cancer care in community-based settings, close to home.
Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies, genomic-based treatment, and immunotherapy. Our highest values are embodied by our outstanding team of highly-trained and dedicated physicians, clinicians and staff.
* Prior to approval
For More Information, Contact:
Florida Cancer Specialists & Research Institute
Shelly Glenn, Chief Marketing & Sales Officer
(813) 281.0088 ext. 327
Ganick Communications, Inc.